IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nanobac Pharmaceuticals Inc (NNBP)

CUSIP: 63007M102 | NYSE | 2 institutional holders

Quarters

Q1 2022Q2 2021Q1 2021Q4 2020Q3 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2022

Captrust Financial Advisors631
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Captrust Financial Advisors
631$00.0%IndexLowRaleigh, NC2022-05-16